首页|布地奈德联合沙美特罗/丙酸氟替卡松干粉治疗支气管哮喘合并过敏性鼻炎的临床效果分析

布地奈德联合沙美特罗/丙酸氟替卡松干粉治疗支气管哮喘合并过敏性鼻炎的临床效果分析

扫码查看
目的 分析布地奈德联合沙美特罗/丙酸氟替卡松干粉治疗支气管哮喘合并过敏性鼻炎的临床效果.方法 随机选取2022年4月—2023年5月无锡市儿童医院儿童耳鼻咽喉科收治的150例支气管哮喘伴过敏性鼻炎患儿为研究对象,按奇偶数法分组,各75例.一般组采用沙美特罗/丙酸氟替卡松干粉,考察组在一般组的基础上联合使用布地奈德鼻喷剂.对比两组患者的症状消失时间、哮喘症状积分、鼻炎症状积分、生活质量评分及血清炎症因子.结果 考察组患儿咳嗽消失时间(3.23±1.25)d、气促消失时间(3.27±1.22)d、鼻塞消失时间(3.61±0.74)d、鼻痒消失时间(3.27±0.38)d均短于一般组,差异有统计学意义(t=9.768、8.546、11.309、20.752,P均<0.05).治疗前,两组患儿哮喘症状评分、鼻炎症状评分、生存质量评分对比,差异无统计学意义(P均>0.05);治疗后,考察组患儿哮喘症状评分、鼻炎症状评分、生存质量评分优于一般组,差异有统计学意义(P均<0.05).治疗前,两组患儿血清炎性因子水平对比,差异无统计学意义(P>0.05);治疗后,考察组患儿血清炎性因子水平低于一般组,差异有统计学意义(P<0.05).结论 布地奈德联合沙美特罗/丙酸氟替卡松干粉用于支气管哮喘、变应性鼻炎的疗效肯定,可减轻哮喘、鼻炎症状,治疗安全性较高.
Clinical Effect Analysis of Budesonide Combined with Salmeterol/Flutica-sone Propionate Dry Powder in the Treatment of Bronchial Asthma Com-bined with Allergic Rhinitis
Objective To analyze the clinical effect of budesonide combined with salmeterol/fluticasone propionate dry powder in the treatment of bronchial asthma combined with allergic rhinitis.Methods A total of,150 children with bronchial asthma with allergic rhinitis admitted to the Department of Pediatric Otorhinolaryngology of Wuxi Children's Hospital from April 2022 to May 2023 were randomly selected as the study objects and grouped into 75 cases each ac-cording to the odd-even method.The general group used salmeterol/fluticasone propionate dry powder,and the investi-gation group used budesonide nasal spray in combination with the general group.The symptom disappearance time,asthma symptom score,rhinitis symptom score,quality of life score and serum inflammatory factor were compared be-tween the two groups.Results The children in the investigation group cough disappearance was(3.23±1.25)d,short-ness of breath disappearance was(3.27±1.22)d,nasal congestion disappearance was(3.61±0.74)d,and itchiness dis-appearance was(3.27±0.38)d,which were shorter than those of the general group,and the differences were statisti-cally significant(t=9.768,8.546,11.309,20.752,all P<0.05).Before treatment,the difference was not statistically sig-nificant when comparing the asthma symptom scores,rhinitis symptom scores,and quality of survival scores of the children in the two groups(all P>0.05);after treatment,the children in the investigation group had better asthma symptom scores,rhinitis symptom scores,and quality of survival scores than the general group,and the differences were statistically significant(all P<0.05).Before treatment,the comparison of serum inflammatory factor levels of chil-dren in the two groups,the difference was not statistically significant(P>0.05);after treatment,the serum inflamma-tory factor levels of children in the investigation group were lower than those of the general group,and the difference was statistically significant(P<0.05).Conclusion The efficacy of budesonide combined with salmeterol/fluticasone pro-pionate dry powder for bronchial asthma and allergic rhinitis is certain,and it can reduce the symptoms of asthma and rhinitis,and the therapeutic safety is high.

Bronchial asthmaBudesonideAllergic rhinitisSalmeterol

陆泓烨、邹凤、周琪

展开 >

无锡市儿童医院儿童耳鼻咽喉科,江苏 无锡 214000

支气管哮喘 布地奈德 过敏性鼻炎 沙美特罗

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(17)